Baylor College of Medicine's Arthur Beaudet says he is seeing how genomic testing and sequencing is beginning to have an impact on how physicians approach treating rare disorders.

Beaudet, who has been treating children with rare disorders for 40 years, told MedScape at the recent Future of Genomic Medicine Conference that genetic testing began having an impact on his field through newborn screening. GlobalGenes.org has posted the interview on its site.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Rare Ones

Spreading the Word

In This Case…

The Healthiest

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.